beta-lactams has been researched along with cefotaxime in 78 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (cefotaxime) | Trials (cefotaxime) | Recent Studies (post-2010) (cefotaxime) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 5,747 | 727 | 790 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (15.38) | 18.7374 |
1990's | 4 (5.13) | 18.2507 |
2000's | 21 (26.92) | 29.6817 |
2010's | 30 (38.46) | 24.3611 |
2020's | 11 (14.10) | 2.80 |
Authors | Studies |
---|---|
Kato, M; Kobayashi, M; Ueda, I | 1 |
Klesel, N; Limbert, M | 1 |
Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
Barry, AL; Jones, RN; Thornsberry, C | 1 |
Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C | 2 |
Verbist, L | 1 |
Fu, KP; Neu, HC | 1 |
Slack, MP | 1 |
Neu, HC | 1 |
Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
Neu, HC; Prince, AS | 1 |
Grebe, T; Hakenbeck, R | 1 |
Verbist, L; Verhaegen, J | 1 |
Greenman, J; Hassan, IJ; Millar, MR; Stark, RM | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Bonnet, R; Chanal, C; De Champs, C; Labia, R; Sampaio, JL; Sirot, D; Sirot, J | 1 |
Aguilar, L; Casal, J; Fenoll, A; Giménez, MJ; Jado, I; Prieto, J; Yuste, J | 1 |
Champelovier, D; Chesnel, L; Croizé, J; Dideberg, O; Lemaire, D; Pernot, L; Vernet, T; Zapun, A | 1 |
Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H | 1 |
Nakayama, A; Takao, A | 1 |
Bamford, DH; Makeyev, EV | 1 |
Dower, SK; Moore, LJ; Pridmore, AC; Read, RC | 1 |
Lee, WS; Lin, ML; Liu, CY; Wang, FD | 1 |
Almela, M; Gómez, J; Marco, F; Mensa, J; Ortega, M; Soriano, A | 1 |
Datta, P; Gupta, V; Mishra, B; Thakur, A | 1 |
Amicosante, G; Brigante, G; Caporale, B; De Santis, F; Ettorre, D; Mazza, F; Perilli, M; Pochetti, G; Segatore, B; Tavìo, MM | 1 |
Cheung, TK; Chu, YW; Hui, IS; Kam, KM; Ngan, JY; Tsang, GK | 1 |
Majiduddin, FK; Palzkill, T | 1 |
Caballero-Granado, FJ; Docobo-Pérez, F; García-Curiel, A; Jiménez-Mejías, ME; Moreno-Maqueda, I; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
Chuang, YM; Ho, YC; Hsueh, PR; Teng, LJ; Tseng, SP | 1 |
Cebrián, L; Escribano, I; Rodríguez, JC; Royo, G | 1 |
Dower, SK; Dowson, CG; Gilbey, AM; Moore, LJ; Pridmore, AC; Read, RC | 1 |
Buijs, J; Dofferhoff, AS; Mouton, JW; van der Meer, JW; Wagenvoort, JH | 1 |
Livermore, DM; Miossec, C; Mushtaq, S; Warner, M; Woodford, N | 1 |
Ahsman, MJ; Mathot, RA; Tibboel, D; Wildschut, ED | 1 |
De Wals, PY; Doucet, N; Pelletier, JN | 1 |
Arakere, G; Gopal, B; Nadig, S; Navratna, V; Prasad, K; Sood, V | 1 |
Appelbaum, PC; Kosowska-Shick, K; McGhee, PL | 1 |
Badiou, C; Benito, Y; Bes, M; Boisset, S; Bowden, MG; Cheung, AL; Choudhury, P; Dumitrescu, O; Etienne, J; Lina, G; Vandenesch, F; Wolz, C | 1 |
Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L | 1 |
Chanda, PK; Mehta, S; Paul, A; Plata, KB; Riosa, S; Rosato, AE; Rosato, RR; Singh, C | 1 |
Doudi, M; Naghsh, N; Setorki, M | 1 |
Hu, CQ; Hu, QX; Li, YP; Wang, MJ; Zhang, WQ; Zhang, X | 1 |
Chan, KW; Huang, YC; Kao, CC; Lin, CF; Liu, JW; Liu, PY; Shi, ZY; Shyu, CL; Tung, KC; Wu, ZY | 1 |
Singh, HL; Singh, RM | 1 |
Chang, SC; Chen, PC; Huang, IW; Lai, JF; Lauderdale, TL; Shiau, YR; Tan, MC; Wang, HY; Wang, JT | 1 |
Carlson, EE; Kocaoglu, O | 1 |
Nørskov-Lauritsen, N; Søndergaard, A; Tristram, SG; Witherden, EA | 1 |
Dersch, R; Freitag, MH; Meerpohl, JJ; Rauer, S; Schmidt, S; Sommer, H | 1 |
Kirikae, T; Miyoshi-Akiyama, T; Ohara, H; Pokhrel, BM; Shimada, K; Shrestha, B; Tada, T | 1 |
Pfausler, B; Schmutzhard, E | 1 |
Bjørnvad, CR; Bortolaia, V; Espinosa-Gongora, C; Guardabassi, L; Jessen, LR; Langebæk, R; Shah, SQ | 1 |
Coates, L; Cooper, JB; Erskine, PT; Ginell, SL; Ostermann, A; Schrader, TE; Tomanicek, SJ; Vandavasi, VG; Weiss, KL | 1 |
Hulin, A; Khoudour, N; Legrand, T; Tournier, N; Vodovar, D | 1 |
Fröding, I; Giske, CG; Vondracek, M | 1 |
Allerberger, F; Jesumirhewe, C; Lepuschitz, S; Ruppitsch, W; Springer, B | 1 |
Abat, C; Diene, SM; Raoult, D; Rolain, JM | 1 |
Hatti, M; Odenholt, I; Resman, F; Solomonidi, N; Tham, J | 1 |
Hackel, MA; Iaconis, JP; Karlowsky, JA; Sahm, DF | 1 |
Bähr, T; Gatermann, SG; Kohlmann, R | 1 |
Cecchini, J; Habibi, A; Hulin, A; Mekontso Dessap, A; Razazi, K | 1 |
Cha, HJ; Jeong, JH; Kim, YG | 1 |
Brochmann, PR; Brodersen, GH; Guardabassi, L; Hesketh, A; Jana, B | 1 |
Arakawa, Y; Hayashi, W; Kimura, K; Koide, S; Nagano, N; Nagano, Y; Tanaka, H; Taniguchi, Y | 1 |
Andersson, DI; Linkevicius, M; Munck, C; Porse, A; Rosenkilde, CEH; Sommer, MOA | 1 |
Sharma, AK; Vats, P | 1 |
Boxer, SG; Kozuch, J; Schneider, SH | 1 |
Li, D; Li, H; Liu, Z; Ma, X; Tang, H; Tang, Y; Yu, W | 1 |
Maquieira, Á; Morais, S; Peña-Mendizabal, E | 1 |
Booncharoen, S; Chaiyapoke, C; Chanawong, A; Lulitanond, A; Srisrattakarn, A; Tavichakorntrakool, R; Tippayawat, P; Wongthong, S | 1 |
Courter, J; Mortensen, JE; Murphy, ME; Powell, E | 1 |
Carolan, JC; Margalit, A; Walsh, F | 1 |
Coronel, P; Del Río, I; Domenech, M; Gimeno, M; González-Camacho, F; Lago, D; Llamosí, M; López Ruiz, B; Pérez-García, C; Sempere, J; Yuste, J | 1 |
Béranger, A; Bille, E; Callot, D; Chouchana, L; Debray, A; Hirt, D; Oualha, M; Renolleau, S; Tréluyer, JM | 1 |
Bozdoğan, B; Tristram, S; Yalçın, M | 1 |
Eliasson, E; Furebring, M; Lipcsey, M; Smekal, AK | 1 |
Ding, Y; Du, Y; Kang, W; Lai, J; Li, Y; Liu, X; Wang, J; Wang, Y; Xiao, R; Zhang, J; Zou, P | 1 |
3 review(s) available for beta-lactams and cefotaxime
Article | Year |
---|---|
Antipseudomonal beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1981 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Doxycycline; Female; Humans; Lyme Neuroborreliosis; Penicillins | 2015 |
75 other study(ies) available for beta-lactams and cefotaxime
Article | Year |
---|---|
Synthesis of 7 beta-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]-3-cephem-4- carboxylic acid (ceftizoxime), a new semisynthetic cephalosporin antibiotic. I. An improved method for the preparation of 7-amino-3-methylene- and 7-amino-3-hydroxycepha
Topics: beta-Lactams; Cefotaxime; Ceftizoxime; Chemical Phenomena; Chemistry; Lactams; Molecular Conformation | 1988 |
[Studies on the effects of a modified immunoglobulin and beta-lactam antibiotics in the experimental mouse septicemia (author's transl)].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; gamma-Globulins; Mice; Sepsis; Time Factors | 1981 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1980 |
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Moxalactam | 1981 |
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Enterobacteriaceae Infections; Fermentation; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam | 1981 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics.
Topics: Amino Acid Sequence; Aminoacyltransferases; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactams; Carrier Proteins; Cefotaxime; Dose-Response Relationship, Drug; Hexosyltransferases; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Oxacillin; Penicillin-Binding Proteins; Peptidyl Transferases; Piperacillin; Polymerase Chain Reaction; Streptococcus pneumoniae | 1996 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
Absence of a post-antibiotic effect (PAE) of beta-lactams against Helicobacter pylori NCTC 11637.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cefixime; Cefotaxime; Cephalosporins; Colony Count, Microbial; Culture Media; Helicobacter pylori; Microbial Sensitivity Tests; Penicillins | 1998 |
Multicenter survey of the in vitro activity of four expanded-spectrum beta-lactams against consecutive contemporary clinical isolates.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactams; Cefotaxime; Cefpodoxime; Ceftazidime; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests; Monobactams | 1998 |
A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; beta-Lactams; Brazil; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; DNA, Bacterial; Enterobacteriaceae; Gene Transfer Techniques; Humans; Kinetics; Molecular Sequence Data; Sequence Homology, Amino Acid | 2000 |
Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model.
Topics: Amoxicillin; Animals; Antibodies, Bacterial; Antibody Specificity; beta-Lactams; Cefotaxime; Disease Models, Animal; Humans; Immune Sera; Mice; Mice, Inbred BALB C; Pneumococcal Infections; Sepsis; Streptococcus pneumoniae; Treatment Outcome | 2002 |
The structural modifications induced by the M339F substitution in PBP2x from Streptococcus pneumoniae further decreases the susceptibility to beta-lactams of resistant strains.
Topics: Acylation; beta-Lactam Resistance; beta-Lactams; Binding Sites; Carrier Proteins; Cefotaxime; Crystallization; Hydrogen-Ion Concentration; Kinetics; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Penicillin G; Penicillin-Binding Proteins; Phenotype; Point Mutation; Serine; Streptococcus pneumoniae | 2003 |
Efficacy of amikacin combinations for nocardiosis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim | 2003 |
Beta-lactam resistance in Streptococcus mitis isolated from saliva of healthy subjects.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Carrier Proteins; Cefaclor; Cefotaxime; Female; Hexosyltransferases; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Saliva; Sequence Analysis, DNA; Streptococcus mitis | 2003 |
Evolutionary potential of an RNA virus.
Topics: Adaptation, Physiological; Bacteriophage phi 6; beta-Lactamases; beta-Lactams; Cefotaxime; Drug Resistance, Bacterial; Escherichia coli; Evolution, Molecular; Microbial Sensitivity Tests; Mutation; Pseudomonas syringae; Recombination, Genetic; RNA, Double-Stranded | 2004 |
The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cell Wall; Cephalosporins; Genes, Reporter; HeLa Cells; Humans; Interleukin-8; Lactams; Lipopolysaccharide Receptors; Luciferases; Membrane Glycoproteins; Microbial Sensitivity Tests; Plasmids; Receptors, Cell Surface; Streptococcus pneumoniae; Toll-Like Receptor 2; Toll-Like Receptors; Transfection; Vancomycin | 2004 |
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam | 2004 |
In vitro antagonism between beta-lactam and macrolide in Streptococcus pneumoniae: how important is the antibiotic order?
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Colony Count, Microbial; Drug Administration Schedule; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae | 2004 |
Prevalence of clinical strains resistant to various beta-lactams in a tertiary care hospital in India.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; India; Microbial Sensitivity Tests; Prevalence | 2004 |
Overexpression system and biochemical profile of CTX-M-3 extended-spectrum beta-lactamase expressed in Escherichia coli.
Topics: beta-Lactamases; beta-Lactams; Biotechnology; Cefotaxime; Citrobacter freundii; Escherichia coli; Kinetics; Recombinant Proteins; Substrate Specificity; Up-Regulation | 2004 |
Emergence of CTX-M-type beta-lactam resistance in Shigella spp. in Hong Kong.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Dysentery, Bacillary; Hong Kong; Humans; Microbial Sensitivity Tests; Shigella | 2005 |
Amino acid residues that contribute to substrate specificity of class A beta-lactamase SME-1.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Binding Sites; Carbapenems; Cefotaxime; Codon; Escherichia coli; Imipenem; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Penicillins; Substrate Specificity | 2005 |
Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ceftriaxone; Endocarditis, Bacterial; Half-Life; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae | 2005 |
Emergence of cefotaxime resistance in Citrobacter freundii causing necrotizing fasciitis and osteomyelitis.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Enterobacteriaceae Infections; Ertapenem; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Osteomyelitis; Wounds and Injuries | 2006 |
In vitro generation of Salmonella spp. mutants following repeated exposure to beta-lactam antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation; Salmonella | 2006 |
Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; HeLa Cells; Humans; Lipopolysaccharide Receptors; Microbial Sensitivity Tests; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Streptococcus pneumoniae; Toll-Like Receptor 2 | 2007 |
Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefotaxime; Ceftazidime; Colony Count, Microbial; Dose-Response Relationship, Drug; Endotoxins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas | 2008 |
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Enterobacteriaceae; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure | 2008 |
Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefotaxime; Ceftriaxone; Chromatography, High Pressure Liquid; Humans; Infant, Newborn; Meropenem; Tandem Mass Spectrometry; Thienamycins; Vancomycin | 2009 |
High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cefotaxime; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Substrate Specificity | 2009 |
Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Drug Resistance, Bacterial; Gram-Negative Aerobic Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxalactam; Staphylococcus | 1981 |
Molecular basis for the role of Staphylococcus aureus penicillin binding protein 4 in antimicrobial resistance.
Topics: Ampicillin; Bacterial Proteins; beta-Lactams; Cefotaxime; Crystallography, X-Ray; Drug Resistance, Bacterial; Molecular Sequence Data; Oxacillin; Penicillin-Binding Proteins; Polymerase Chain Reaction; Staphylococcus aureus; Vancomycin Resistance | 2010 |
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Binding, Competitive; Cefotaxime; Ceftaroline; Cephalosporins; Drug Resistance, Microbial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae | 2010 |
Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactams; Cefaclor; Cefotaxime; Cefoxitin; Exotoxins; Female; Gene Expression Regulation, Bacterial; Imipenem; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Trans-Activators | 2011 |
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate | 2012 |
β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Daptomycin; DNA; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Insecta; Larva; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Nafcillin; Oxacillin; Staphylococcal Infections | 2012 |
Comparison of the effects of silver nanoparticles on pathogenic bacteria resistant to beta-lactam antibiotics (ESBLs) as a prokaryote model and Wistar rats as a eukaryote model.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Gram-Negative Bacteria; Klebsiella pneumoniae; Male; Metal Nanoparticles; Microbial Sensitivity Tests; Rats; Rats, Wistar; Silver | 2013 |
The selection of suitable columns for a reversed-phase liquid chromatographic separation of beta-lactam antibiotics and related substances via chromatographic column parameters.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Chromatography, Reverse-Phase; Hydrogen Bonding | 2014 |
Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefotaxime; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests | 2014 |
Comparative evaluation of six phenotypic methods for detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; False Negative Reactions; False Positive Reactions; Female; Humans; India; Male; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests | 2014 |
Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Longitudinal Studies; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus Infections; Proteus mirabilis; Taiwan; Urinary Tract Infections; Young Adult | 2014 |
Profiling of β-lactam selectivity for penicillin-binding proteins in Escherichia coli strain DC2.
Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefotaxime; Cefuroxime; Escherichia coli; Microbial Sensitivity Tests; Penicillin-Binding Proteins | 2015 |
Interspecies transfer of the penicillin-binding protein 3-encoding gene ftsI between Haemophilus influenzae and Haemophilus haemolyticus can confer reduced susceptibility to β-lactam antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefotaxime; Gene Transfer, Horizontal; Haemophilus; Haemophilus influenzae; Homologous Recombination; Microbial Sensitivity Tests; Penicillin-Binding Proteins | 2015 |
Identification of a novel NDM variant, NDM-13, from a multidrug-resistant Escherichia coli clinical isolate in Nepal.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Nepal | 2015 |
Primum non nocere.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Doxycycline; Female; Humans; Lyme Neuroborreliosis; Penicillins | 2016 |
Quantitative assessment of faecal shedding of β-lactam-resistant Escherichia coli and enterococci in dogs.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Shedding; beta-Lactams; Cefotaxime; Denmark; Dogs; Drug Resistance, Bacterial; Enterococcus faecium; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Male; Microbial Sensitivity Tests; Prevalence | 2015 |
Exploring the Mechanism of β-Lactam Ring Protonation in the Class A β-lactamase Acylation Mechanism Using Neutron and X-ray Crystallography.
Topics: Acylation; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catalysis; Catalytic Domain; Cefotaxime; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Models, Molecular; Mutation; Neutron Diffraction; Protein Conformation | 2016 |
Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Humans; Oxacillin; Piperacillin; Ultraviolet Rays | 2016 |
Rapid EUCAST disc diffusion testing of MDR Escherichia coli and Klebsiella pneumoniae: inhibition zones for extended-spectrum cephalosporins can be reliably read after 6 h of incubation.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reagent Kits, Diagnostic; Reproducibility of Results; Time Factors | 2017 |
Carbapenemase-Producing Enterobacteriaceae Isolates from Edo State, Nigeria.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Cefotaxime; Ceftazidime; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Ertapenem; Fluoroquinolones; Humans; Nigeria; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2017 |
How artificial is the antibiotic resistance definition?
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Industry; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Politics; Practice Guidelines as Topic; Streptococcus pneumoniae; Terminology as Topic | 2017 |
Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Bacterial Infections; beta-Lactams; Cefotaxime; Drug Monitoring; Female; Humans; Length of Stay; Male; Meropenem; Patient Readmission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Sweden; Thienamycins | 2018 |
Analysis of Potential β-Lactam Surrogates To Predict
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefotaxime; Ceftazidime; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2018 |
Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefotaxime; Chromosomes, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Microbial Sensitivity Tests; Mutation Rate; Species Specificity | 2018 |
Profound underdosing of β-lactams in patients with sickle-cell disease.
Topics: Amoxicillin; Anemia, Sickle Cell; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefotaxime; Humans; Prospective Studies | 2018 |
Crystal Structures of Penicillin-Binding Protein D2 from Listeria monocytogenes and Structural Basis for Antibiotic Specificity.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cefotaxime; Cefuroxime; Crystallography, X-Ray; Humans; Listeria monocytogenes; Penicillin G; Penicillin-Binding Proteins | 2018 |
Transcriptome analysis of extended-spectrum β-lactamase-producing Escherichia coli and methicillin-resistant Staphylococcus aureus exposed to cefotaxime.
Topics: beta-Lactamases; beta-Lactams; Cefotaxime; Escherichia coli; Gene Expression Profiling; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Transcriptome | 2018 |
Potential effect of selective pressure with different β-lactam molecules on the emergence of reduced susceptibility to β-lactams in group B Streptococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cefotaxime; Ceftibuten; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Penicillins; Streptococcus agalactiae | 2019 |
Collateral sensitivity constrains resistance evolution of the CTX-M-15 β-lactamase.
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Disease Models, Animal; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Female; Gene Transfer, Horizontal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation | 2019 |
Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Southern; Cefotaxime; Cephalosporins; Clavulanic Acid; Humans; Isoelectric Focusing; Kinetics; Mycobacterium tuberculosis; Polymerase Chain Reaction; Tuberculosis | 2019 |
Biosynthetic Incorporation of Site-Specific Isotopes in β-Lactam Antibiotics Enables Biophysical Studies.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Binding Sites; Carbon Isotopes; Cefotaxime; Cephalosporins; Drug Discovery; Drug Resistance, Microbial; Penicillin G; Penicillium; Protein Conformation | 2020 |
Absence of tmRNA Increases the Persistence to Cefotaxime and the Intercellular Accumulation of Metabolite GlcNAc in
Topics: Acetylglucosamine; Aeromonas veronii; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Osmoregulation; Peptidoglycan; Protein Biosynthesis; RNA, Bacterial; Up-Regulation | 2020 |
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests | 2020 |
Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2021 |
Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2021 |
Global protein responses of multidrug resistance plasmid-containing Escherichia coli to ampicillin, cefotaxime, imipenem and ciprofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Imipenem; Plasmids; Proteome; Proteomics | 2022 |
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; COVID-19 Drug Treatment; Drug Resistance, Bacterial; Erythromycin; Humans; Pandemics; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Serogroup; Spain; Streptococcus pneumoniae; Vaccines, Conjugate | 2022 |
Beta-lactam exposure and safety in intermittent or continuous infusion in critically ill children: an observational monocenter study.
Topics: Anti-Bacterial Agents; Bayes Theorem; beta-Lactams; Cefotaxime; Child; Critical Illness; Humans; Infusions, Intravenous; Meropenem; Piperacillin; Prospective Studies | 2023 |
Use of trans-complementation method to determine the effects of various ftsI mutations on β-lactamase-negative ampicillin-resistant (BLNAR) Haemophilus influenzae strains.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mutation | 2022 |
Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Critical Illness; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monobactams; Prospective Studies | 2022 |
Antibiotic susceptibility of
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefotaxime; China; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2023 |